vs
Cooper Companies (The)（COO）与Sylvamo Corp（SLVM）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是Sylvamo Corp的1.4倍（$1.1B vs $755.0M），Cooper Companies (The)净利率更高（7.9% vs -0.4%，领先8.3%），Cooper Companies (The)同比增速更快（4.6% vs -8.0%），Cooper Companies (The)自由现金流更多（$149.9M vs $-59.0M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs -10.0%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
西尔瓦莫公司是全球领先的可持续纸浆与纸品生产商，核心产品包括非涂布印刷纸、包装纸及商用纸浆，业务覆盖北美、欧洲、拉美地区，服务办公耗材、出版、商业印刷、包装等多个领域。
COO vs SLVM — 直观对比
营收规模更大
COO
是对方的1.4倍
$755.0M
营收增速更快
COO
高出12.6%
-8.0%
净利率更高
COO
高出8.3%
-0.4%
自由现金流更多
COO
多$208.9M
$-59.0M
两年增速更快
COO
近两年复合增速
-10.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $755.0M |
| 净利润 | $84.6M | $-3.0M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | — |
| 净利率 | 7.9% | -0.4% |
| 营收同比 | 4.6% | -8.0% |
| 净利润同比 | -28.0% | — |
| 每股收益（稀释后） | $0.42 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOSLVM
| Q1 26 | — | $755.0M | ||
| Q4 25 | $1.1B | $890.0M | ||
| Q3 25 | $1.1B | $846.0M | ||
| Q2 25 | $1.0B | $794.0M | ||
| Q1 25 | $964.7M | $821.0M | ||
| Q4 24 | $1.0B | $970.0M | ||
| Q3 24 | $1.0B | $965.0M | ||
| Q2 24 | $942.6M | $933.0M |
净利润COOSLVM
| Q1 26 | — | $-3.0M | ||
| Q4 25 | $84.6M | $33.0M | ||
| Q3 25 | $98.3M | $57.0M | ||
| Q2 25 | $87.7M | $15.0M | ||
| Q1 25 | $104.3M | $27.0M | ||
| Q4 24 | $117.5M | $81.0M | ||
| Q3 24 | $104.7M | $95.0M | ||
| Q2 24 | $88.9M | $83.0M |
毛利率COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — |
营业利润率COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | 8.9% | ||
| Q3 25 | 16.6% | 11.6% | ||
| Q2 25 | 18.4% | 3.8% | ||
| Q1 25 | 18.9% | 5.4% | ||
| Q4 24 | 19.5% | 11.2% | ||
| Q3 24 | 19.2% | 15.5% | ||
| Q2 24 | 17.2% | 13.1% |
净利率COOSLVM
| Q1 26 | — | -0.4% | ||
| Q4 25 | 7.9% | 3.7% | ||
| Q3 25 | 9.3% | 6.7% | ||
| Q2 25 | 8.7% | 1.9% | ||
| Q1 25 | 10.8% | 3.3% | ||
| Q4 24 | 11.5% | 8.4% | ||
| Q3 24 | 10.4% | 9.8% | ||
| Q2 24 | 9.4% | 8.9% |
每股收益（稀释后）COOSLVM
| Q1 26 | — | $-0.08 | ||
| Q4 25 | $0.42 | $0.81 | ||
| Q3 25 | $0.49 | $1.41 | ||
| Q2 25 | $0.44 | $0.37 | ||
| Q1 25 | $0.52 | $0.65 | ||
| Q4 24 | $0.59 | $1.91 | ||
| Q3 24 | $0.52 | $2.27 | ||
| Q2 24 | $0.44 | $1.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | $766.0M |
| 股东权益账面价值 | $8.2B | $979.0M |
| 总资产 | $12.4B | $2.8B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.78× |
8季度趋势，按日历期对齐
现金及短期投资COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | $110.6M | $198.0M | ||
| Q3 25 | $124.9M | $146.0M | ||
| Q2 25 | $116.2M | $183.0M | ||
| Q1 25 | $100.9M | $220.0M | ||
| Q4 24 | $107.6M | $309.0M | ||
| Q3 24 | $109.7M | $414.0M | ||
| Q2 24 | $112.4M | $213.0M |
总债务COOSLVM
| Q1 26 | — | $766.0M | ||
| Q4 25 | $2.5B | $763.0M | ||
| Q3 25 | $2.4B | $778.0M | ||
| Q2 25 | $2.5B | $767.0M | ||
| Q1 25 | $2.5B | $794.0M | ||
| Q4 24 | $2.6B | $782.0M | ||
| Q3 24 | $2.6B | $883.0M | ||
| Q2 24 | $2.7B | $894.0M |
股东权益COOSLVM
| Q1 26 | — | $979.0M | ||
| Q4 25 | $8.2B | $966.0M | ||
| Q3 25 | $8.4B | $977.0M | ||
| Q2 25 | $8.3B | $959.0M | ||
| Q1 25 | $8.1B | $908.0M | ||
| Q4 24 | $8.1B | $847.0M | ||
| Q3 24 | $7.9B | $937.0M | ||
| Q2 24 | $7.8B | $830.0M |
总资产COOSLVM
| Q1 26 | — | $2.8B | ||
| Q4 25 | $12.4B | $2.8B | ||
| Q3 25 | $12.4B | $2.7B | ||
| Q2 25 | $12.4B | $2.7B | ||
| Q1 25 | $12.2B | $2.6B | ||
| Q4 24 | $12.3B | $2.6B | ||
| Q3 24 | $12.1B | $2.9B | ||
| Q2 24 | $12.0B | $2.7B |
负债/权益比COOSLVM
| Q1 26 | — | 0.78× | ||
| Q4 25 | 0.30× | 0.79× | ||
| Q3 25 | 0.29× | 0.80× | ||
| Q2 25 | 0.30× | 0.80× | ||
| Q1 25 | 0.31× | 0.87× | ||
| Q4 24 | 0.32× | 0.92× | ||
| Q3 24 | 0.33× | 0.94× | ||
| Q2 24 | 0.34× | 1.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $-59.0M |
| 自由现金流率自由现金流/营收 | 14.1% | -7.8% |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | $10.0M |
8季度趋势，按日历期对齐
经营现金流COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $94.0M | ||
| Q3 25 | $261.4M | $87.0M | ||
| Q2 25 | $96.2M | $64.0M | ||
| Q1 25 | $190.6M | $23.0M | ||
| Q4 24 | $268.1M | $164.0M | ||
| Q3 24 | $207.5M | $163.0M | ||
| Q2 24 | $111.0M | $115.0M |
自由现金流COOSLVM
| Q1 26 | — | $-59.0M | ||
| Q4 25 | $149.9M | $38.0M | ||
| Q3 25 | $164.5M | $33.0M | ||
| Q2 25 | $18.1M | $-2.0M | ||
| Q1 25 | $101.2M | $-25.0M | ||
| Q4 24 | $128.1M | $100.0M | ||
| Q3 24 | $118.5M | $119.0M | ||
| Q2 24 | $36.9M | $62.0M |
自由现金流率COOSLVM
| Q1 26 | — | -7.8% | ||
| Q4 25 | 14.1% | 4.3% | ||
| Q3 25 | 15.5% | 3.9% | ||
| Q2 25 | 1.8% | -0.3% | ||
| Q1 25 | 10.5% | -3.0% | ||
| Q4 24 | 12.6% | 10.3% | ||
| Q3 24 | 11.8% | 12.3% | ||
| Q2 24 | 3.9% | 6.6% |
资本支出强度COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | 9.2% | 6.3% | ||
| Q3 25 | 9.1% | 6.4% | ||
| Q2 25 | 7.8% | 8.3% | ||
| Q1 25 | 9.3% | 5.8% | ||
| Q4 24 | 13.7% | 6.6% | ||
| Q3 24 | 8.9% | 4.6% | ||
| Q2 24 | 7.9% | 5.7% |
现金转化率COOSLVM
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 2.85× | ||
| Q3 25 | 2.66× | 1.53× | ||
| Q2 25 | 1.10× | 4.27× | ||
| Q1 25 | 1.83× | 0.85× | ||
| Q4 24 | 2.28× | 2.02× | ||
| Q3 24 | 1.98× | 1.72× | ||
| Q2 24 | 1.25× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
SLVM
| North America | $390.0M | 52% |
| Europe | $190.0M | 25% |
| Latin America | $187.0M | 25% |
